Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial

See also
Status	Clinical Trial	Phase
Completed	`NCT00565123` - Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis	Phase 2/Phase 3
Completed	`NCT00972777` - Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis	Phase 2/Phase 3
Completed	`NCT00798577` - Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment	Phase 4
Completed	`NCT00331916` - AL-15469A for the Treatment of Bacterial Conjunctivitis	Phase 3
Completed	`NCT02432807` - Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis	Phase 3
Completed	`NCT01573910` - An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients	Phase 3
Terminated	`NCT01330355` - Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis	Phase 3
Completed	`NCT00332293` - AL-15469A for the Treatment of Bacterial Conjunctivitis	Phase 3
Completed	`NCT03004924` - Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo	Phase 3
Completed	`NCT02980523` - Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin)	Phase 2
Completed	`NCT01877694` - Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis	Phase 2
Completed	`NCT01175590` - Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle	Phase 3
Completed	`NCT00464438` - A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis	Phase 4
Completed	`NCT00312338` - Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora	Phase 4
Recruiting	`NCT03235141` - Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers	Phase 1
Completed	`NCT00105534` - Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)	Phase 3
Completed	`NCT00105469` - Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)	Phase 3
Recruiting	`NCT06363292` - Study to Evaluate the Safety and Tolerability of PRO-231 Ophthalmic Solution Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects.	Phase 1
Withdrawn	`NCT01238783` - Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis	Phase 2
Terminated	`NCT01740388` - Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis	Phase 3

NCT number	NCT00759148
Study type	Interventional
Source	Alcon Research
Contact
Status	Completed
Phase	Phase 3
Start date	October 2008
Completion date	March 2010

Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms